Cargando…

An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in Mice

Currently licensed vaccines against the influenza A virus (IAV) need to be updated annually to match the constantly evolving antigenicity of the influenza virus glycoproteins, hemagglutinin (HA), and neuramidiase (NA). Attempts to develop universal vaccines that provide broad protection have resulte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Eun Hye, Han, Gye-Yeong, Nguyen, Huan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580491/ https://www.ncbi.nlm.nih.gov/pubmed/28825679 http://dx.doi.org/10.3390/v9080234

Ejemplares similares

Adjuvants and Immunization Strategies to Induce Influenza Virus Hemagglutinin Stalk Antibodies
por: Goff, Peter H., et al.
Publicado: (2013)

Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
por: Steel, John, et al.
Publicado: (2010)

A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice
por: Bliss, Carly M., et al.
Publicado: (2022)

Assessing the Protective Potential of H1N1 Influenza Virus Hemagglutinin Head and Stalk Antibodies in Humans
por: Christensen, Shannon R., et al.
Publicado: (2019)

Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans
por: Nachbagauer, Raffael, et al.
Publicado: (2016)

Hemagglutinin Stalk Antibody Responses Following Trivalent Inactivated Influenza Vaccine Immunization of Pregnant Women and Association With Protection From Influenza Virus Illness
por: Dhar, Nisha, et al.
Publicado: (2020)

Mucosal Immunization with Recombinant Adenovirus Encoding Soluble Globular Head of Hemagglutinin Protects Mice Against Lethal Influenza Virus Infection
por: Kim, Joo Young, et al.
Publicado: (2013)

Protective Immunity Based on the Conserved Hemagglutinin Stalk Domain and Its Prospects for Universal Influenza Vaccine Development
por: Khanna, Madhu, et al.
Publicado: (2014)

Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
por: Pardi, Norbert, et al.
Publicado: (2018)

Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts
por: Nachbagauer, Raffael, et al.
Publicado: (2019)

The influenza virus hemagglutinin head evolves faster than the stalk domain
por: Kirkpatrick, Ericka, et al.
Publicado: (2018)

Hemagglutinin stalk-based monoclonal antibody elicits broadly reactivity against group 1 influenza A virus
por: Huang, Jingjin, et al.
Publicado: (2020)

An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations
por: Rajendran, Madhusudan, et al.
Publicado: (2018)

Baculovirus Displaying Hemagglutinin Elicits Broad Cross-Protection against Influenza in Mice
por: Sim, Sang-Hee, et al.
Publicado: (2016)

Group 1 and group 2 hemagglutinin stalk antibody response according to age
por: Sánchez-de Prada, Laura, et al.
Publicado: (2023)

Hemagglutinin stalk-binding antibodies enhance effectiveness of neuraminidase inhibitors against influenza via Fc-dependent effector functions
por: Zhang, Ali, et al.
Publicado: (2022)

Natural and directed antigenic drift of the H1 influenza virus hemagglutinin stalk domain
por: Anderson, Christopher S., et al.
Publicado: (2017)

Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients
por: Aydillo, Teresa, et al.
Publicado: (2020)

An Inactivated Influenza Virus Vaccine Approach to Targeting the Conserved Hemagglutinin Stalk and M2e Domains
por: Sun, Weina, et al.
Publicado: (2019)

Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines
por: Olukitibi, Titus Abiola, et al.
Publicado: (2022)

Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model
por: Jacobsen, Henning, et al.
Publicado: (2017)

Mutations in the Hemagglutinin Stalk Domain Do Not Permit Escape from a Protective, Stalk-Based Vaccine-Induced Immune Response in the Mouse Model
por: Roubidoux, Ericka Kirkpatrick, et al.
Publicado: (2021)

Influenza Vaccination Results in Differential Hemagglutinin Stalk-Specific Fc-Mediated Functions in Individuals Living With or Without HIV
por: Motsoeneng, Boitumelo M., et al.
Publicado: (2022)

Towards a novel influenza vaccine: engineering of hemagglutinin on a platform of adenovirus dodecahedron
por: Naskalska, Antonina, et al.
Publicado: (2013)

Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus
por: Park, Jae-Keun, et al.
Publicado: (2018)

Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies
por: Carreño, Juan Manuel, et al.
Publicado: (2020)

Glycan Masking of Hemagglutinin for Adenovirus Vector and Recombinant Protein Immunizations Elicits Broadly Neutralizing Antibodies against H5N1 Avian Influenza Viruses
por: Lin, Shih-Chang, et al.
Publicado: (2014)

Publisher Correction: Natural and directed antigenic drift of the H1 influenza virus hemagglutinin stalk domain
por: Anderson, Christopher S., et al.
Publicado: (2018)

Publisher Correction: Natural and directed antigenic drift of the H1 influenza virus hemagglutinin stalk domain
por: Anderson, Christopher S., et al.
Publicado: (2018)

Cross-lineage protection by human antibodies binding the influenza B hemagglutinin
por: Liu, Yi, et al.
Publicado: (2019)

Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody
por: Chen, Jianjun, et al.
Publicado: (2007)

A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice
por: Nachbagauer, Raffael, et al.
Publicado: (2016)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
por: Asthagiri Arunkumar, Guha, et al.
Publicado: (2019)

Influenza H1 Mosaic Hemagglutinin Vaccine Induces Broad Immunity and Protection in Mice
por: Corder, Brigette N., et al.
Publicado: (2019)

Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge
por: van der Lubbe, Joan E. M., et al.
Publicado: (2018)

Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice
por: Puente-Massaguer, Eduard, et al.
Publicado: (2023)

Protective Efficacy of an Orf Virus-Vector Encoding the Hemagglutinin and the Nucleoprotein of Influenza A Virus in Swine
por: Joshi, Lok R., et al.
Publicado: (2021)

Impact of Preexisting Adenovirus Vector Immunity on Immunogenicity and Protection Conferred with an Adenovirus-Based H5N1 Influenza Vaccine
por: Pandey, Aseem, et al.
Publicado: (2012)

Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins
por: Blanchfield, Kristy, et al.
Publicado: (2014)

Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus
por: Klausberger, Miriam, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7s2c0g8g6665ll7f7ts4adnqeh